t(9;19)(q22;p13) in Acute Myelomonocytic Leukemia

被引：0

作者：

Safavi, Moeinadin ^{[1
,2
]}

Safaei, Akbar ^{[2
]}

Hosseini, Marzieh ^{[2
]}

机构：

[1] Univ Tehran, Fac Med, Dept Pathol, Mol Pathol & Cytogenet Ward, Tehran, Iran

[2] Shiraz Univ, Fac Med, Dept Pathol, Mol Pathol & Cytogenet Ward, Shiraz, Iran

来源：

TURKISH JOURNAL OF HEMATOLOGY | 2018年 / 35卷 / 01期

关键词：

Acute myeloid leukemia; Cytogenetic; Monocytic differentiation;

D O I：

10.4274/tjh.2017.0368

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：89 / 90

页数：2

共 3 条

[1] Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state [J].

Bounamici, S ;

Ottaviani, E ;

Testoni, N ;

Montefusco, V ;

Visani, G ;

Bonifazi, F ;

Amabile, M ;

Terragna, C ;

Ruggeri, D ;

Piccaluga, PP ;

Isidori, A ;

Malagola, M ;

Baccarani, M ;

Tura, S ;

Martinelli, G .

BLOOD, 2002, 99 (02) :443-449

[2] Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitution [J].

Ostronoff, Fabiana ;

Bueso-Ramos, Carlos ;

Cortes, Jorge ;

Giralt, Sergio .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (08) :744-747

[3]

Yang JJ, 2017, CANC CYTOGENETICS

← 1 →